In patients with suspected coronary artery disease as well as in patients with chronic kidney disease, intermediate CD14++C16++ monocytes independently predicted future cardiovascular events in large patient cohorts9, 10 and correlated with markers of inflammation and fibronolysis17. Here, CD14 is linked to chronic kidney disease.